Watson Pharmaceuticals (WPI) Q1 2012 Earnings Call April 30, 2012 8:30 am ET Executives Patricia L. Eisenhaur - Vice President of Investor Relations & Corporate Communications Paul M. Bisaro - Chief Executive Officer, President and Director R. Todd Joyce - Chief Financial Officer, Executive Vice President, Principal Accounting Officer, Corporate Controller and Treasurer Albert Paonessa - Chief Operating Officer of Distribution Division and Executive Vice President of Distribution Division George Frederick Wilkinson - Executive Vice President of Global Brands Sigurdur Oli Olafsson - Executive Vice President of Global Generics Analysts Michael Faerm - Crédit Suisse AG, Research Division Randall Stanicky - Canaccord Genuity, Research Division Timothy Chiang - CRT Capital Group LLC, Research Division Corey B. Davis - Jefferies & Company, Inc., Research Division Gregory B. Gilbert - BofA Merrill Lynch, Research Division Christopher Schott - JP Morgan Chase & Co, Research Division David G. Buck - The Buckingham Research Group Incorporated Jami Rubin - Goldman Sachs Group Inc., Research Division Frank H. Pinkerton - SunTrust Robinson Humphrey, Inc., Research Division Gary Nachman - Susquehanna Financial Group, LLLP, Research Division David Risinger - Morgan Stanley, Research Division David Amsellem - Piper Jaffray Companies, Research Division Marc Goodman - UBS Investment Bank, Research Division Elliot Wilbur - Needham & Company, LLC, Research Division Shibani Malhotra - RBC Capital Markets, LLC, Research Division Ken Cacciatore - Cowen and Company, LLC, Research Division PresentationOperator
Good morning. My name is Therese, and I will be your conference operator today. At this time I would like to welcome everyone to the Watson Pharmaceuticals First Quarter Earnings Conference Call. [Operator Instructions] I would now like to turn the call over to Patty Eisenhaur. Go ahead, Patty. Patricia L. Eisenhaur Thank you, Therese, and good morning, everyone. I'd like to welcome you to Watson's First Quarter 2012 Earnings Conference Call. Earlier this morning, Watson issued a press release reporting its earnings for the first quarter ended March 31, 2012. The press release is available on our website at www.watson.com. Additionally, we are conducting a live webcast of this call, which will also be available on our website after the call's conclusion.
Watson Pharmaceuticals (NYSE:WPI) is trading at unusually high volume Tuesday with 2.2 million shares changing hands. It is currently at two times its average daily volume and trading up $3.01 (+2.4%).
Watson Pharmaceuticals (NYSE:WPI) hit a new 52-week high Monday as it is currently trading at $127.42, above its previous 52-week high of $126.53 with 1.3 million shares traded as of 9:35 a.m. ET. Average volume has been 1.1 million shares over the past 30 days.
Watson Pharmaceuticals (NYSE:WPI) is trading at unusually high volume Tuesday with 2.8 million shares changing hands. It is currently at 2.7 times its average daily volume and trading up $2.55 (+2.1%).